"
Team:WLC-Milwaukee/Norovirus
From 2014.igem.org
Mwmortensen (Talk | contribs) (Created page with "{{Team:WLC-Test}} <html><body> <div class ="mainCont" style="width: 85%"> <table><tr><td> <p>Another aspect of our plasmid is the addition of an anti-norovirus monoclonal antibod...") |
Mwmortensen (Talk | contribs) |
||
| Line 5: | Line 5: | ||
<p>Another aspect of our plasmid is the addition of an anti-norovirus monoclonal antibody to the plasmid. Noroviruses are one of the leading causes of gastroenteritis worldwide. This is due to the relative ease of transmission of the virus. The norovirus is usually transmitted via contaminated food and water, the fecal-oral route, or from the vomit from a person who has been infected. The norovirus particles can remain on environmental surfaces or can be aerosolized. All of these methods can cause infection when a susceptible person comes into contact with the viral particles.[1] </p><p> | <p>Another aspect of our plasmid is the addition of an anti-norovirus monoclonal antibody to the plasmid. Noroviruses are one of the leading causes of gastroenteritis worldwide. This is due to the relative ease of transmission of the virus. The norovirus is usually transmitted via contaminated food and water, the fecal-oral route, or from the vomit from a person who has been infected. The norovirus particles can remain on environmental surfaces or can be aerosolized. All of these methods can cause infection when a susceptible person comes into contact with the viral particles.[1] </p><p> | ||
People that are most susceptible to the norovirus include children, the elderly, and the immunocompromised.[2] When these populations are infected, the virus will generally cause gastroenteritis – a 2-3 day long sickness characterized by “nausea, vomiting, abdominal cramps, myalgias, and non-bloody diarrhea”.[1] These types of diarrheal sicknesses are the leading cause of pediatric death within developing countries.[3] Due to the prevalence of illness and death caused by the norovirus in developing countries, we thought it was fitting to include an extra benefit to our probiotic: an anti-norovirus monoclonal antibody.</p> | People that are most susceptible to the norovirus include children, the elderly, and the immunocompromised.[2] When these populations are infected, the virus will generally cause gastroenteritis – a 2-3 day long sickness characterized by “nausea, vomiting, abdominal cramps, myalgias, and non-bloody diarrhea”.[1] These types of diarrheal sicknesses are the leading cause of pediatric death within developing countries.[3] Due to the prevalence of illness and death caused by the norovirus in developing countries, we thought it was fitting to include an extra benefit to our probiotic: an anti-norovirus monoclonal antibody.</p> | ||
| - | <p>References<div class="ref> | + | <p>References<div class="ref"> |
[1] Patel, M. M., et al. (2009). "Noroviruses: a comprehensive review." J Clin Virol 44(1): 1-8. | [1] Patel, M. M., et al. (2009). "Noroviruses: a comprehensive review." J Clin Virol 44(1): 1-8. | ||
[2] Glass, R. I., et al. (2009). "Norovirus gastroenteritis." N Engl J Med 361(18): 1776-1785. | [2] Glass, R. I., et al. (2009). "Norovirus gastroenteritis." N Engl J Med 361(18): 1776-1785. | ||
Revision as of 22:51, 17 October 2014
|
|
Another aspect of our plasmid is the addition of an anti-norovirus monoclonal antibody to the plasmid. Noroviruses are one of the leading causes of gastroenteritis worldwide. This is due to the relative ease of transmission of the virus. The norovirus is usually transmitted via contaminated food and water, the fecal-oral route, or from the vomit from a person who has been infected. The norovirus particles can remain on environmental surfaces or can be aerosolized. All of these methods can cause infection when a susceptible person comes into contact with the viral particles.[1] People that are most susceptible to the norovirus include children, the elderly, and the immunocompromised.[2] When these populations are infected, the virus will generally cause gastroenteritis – a 2-3 day long sickness characterized by “nausea, vomiting, abdominal cramps, myalgias, and non-bloody diarrhea”.[1] These types of diarrheal sicknesses are the leading cause of pediatric death within developing countries.[3] Due to the prevalence of illness and death caused by the norovirus in developing countries, we thought it was fitting to include an extra benefit to our probiotic: an anti-norovirus monoclonal antibody. References
[1] Patel, M. M., et al. (2009). "Noroviruses: a comprehensive review." J Clin Virol 44(1): 1-8.
[2] Glass, R. I., et al. (2009). "Norovirus gastroenteritis." N Engl J Med 361(18): 1776-1785.
[3] O'Ryan, M., et al. (2005). "A millennium update on pediatric diarrheal illness in the developing world." Semin Pediatr Infect Dis 16(2): 125-136.
|
